Pharmaceutical Industry Spending More, Seeing Fewer Returns On R&D, Survey Shows

Financial Times: Pharma industry’s return on R&D investment falls sharply
“The world’s 12 biggest drug companies are making a return of just 3.2 percent on their research and development spending this year — down from 10.1 percent in 2010, according to Deloitte’s annual survey of pharma R&D investment. At the same time the average cost of bringing a drug to market has soared to a record $2bn from $1.5bn in 2016 and $1.2bn in 2010, when the professional services firm launched its pharma survey…” (Cookson, 12/13).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.